Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,689-2,700 of 10,612

Behavioral study icon

CompletedNCT00956605

A study of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 10 Years to 15 Years

Countries: United States
Sponsor: Tufts Medical Center
Condition: ADHD

Drug study icon

CompletedNCT03365362

A study of Directly Observed and Long-term Varenicline

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Albert Einstein College of Medicine
Condition: Addiction

Other study type icon

CompletedNCT02357173

A study of E-cigarettes in Current Cigarette Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherOver 18 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Behavioral study icon

CompletedNCT00984698

A study of Group Psychotherapy for Veterans and Military Personnel With PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Arizona
Condition: PTSD, Depression

Drug study icon

CompletedNCT05273567

A study of Guanfacine-er for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Drug study icon

TerminatedNCT02234011

A study of Intranasal Ketamine for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: OCD

Drug study icon

CompletedNCT04030143

A study of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity, Schizophrenia

Behavioral study icon

CompletedNCT05777161

A study of Parent-coached Exposure Therapy for Children With Anxiety Disorders and OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCD, AnxietyBehavioralFrom 7 Years to 75 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: OCD, Anxiety

Drug study icon

CompletedNCT00762268

A study of SAMe for Treatment-Resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT03854409

A study of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity, Schizophrenia

Drug study icon

CompletedNCT04512066

A study of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in people with an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

This study is completed in the United States, in Japan, in Russia, .... It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States, Japan, Russia, ...
Sponsor: Hoffmann-La Roche
Condition: Schizophrenia

Drug study icon

CompletedNCT06229977

A study of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Rodrigo Machado-Vieira, MD, PhD, MSc
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.